DFB Pharmaceuticals
Practical innovations for life
banenr-paclitaxel.jpg

NanOlogy

Big ideas in action.

 

Clinical Development of a Submicron Particle Drug Platform to Treat Cancer


nanology - logo.png

DFB formed NanOlogy™ in 2015 to transform systemic chemotherapy into local delivery to treat cancer and other serious illnesses.

NanOlogy, LLC is a company formed in collaboration with CritiTech, Inc. of Lawrence, KS, and US Biotest, Inc. of San Luis Obispo, CA, to finance and develop a breakthrough submicron particle production technology platform aimed at transforming systemic chemotherapy into local delivery - directly to the site of disease - to improve the lives of patients with cancer and other serious illnesses.

visit the Nanology website >

see our clinical drug development pipeline >